We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

2 hedge funds and large institutions have $442 invested in Avadel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 202 closing their positions.

New
Increased
Maintained
Reduced
Closed

75.53% less ownership

Funds ownership: 75.53% → 0% (-76%)

99% less funds holding

Funds holding: 207 → 2 (-205)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.6B → $442 (-$1.6B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 202

Holders
2
Holders Change
-205
Holders Change %
-99.03%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
202
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$152M
2
GJL
Gendell Jeffrey L
-$103M
3
WAM
Weiss Asset Management
Massachusetts
-$97.3M
4
TAL
TIG Advisors LLC
New York
-$83.2M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$64.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
– -$13.1M -607,268 Closed
Bank of America
27
Bank of America
North Carolina
– -$13.1M -606,106 Closed
KCM
28
Knoll Capital Management
Florida
– -$12.9M -600,000 Closed
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
– -$12.6M -585,102 Closed
MWM
30
Modera Wealth Management
New Jersey
– -$12M -558,972 Closed
CM
31
Caption Management
Oklahoma
– -$11.6M -536,838 Closed
Morgan Stanley
32
Morgan Stanley
New York
– -$11.4M -529,074 Closed
AAM
33
Alpine Associates Management
Florida
– -$11.3M -525,550 Closed
CIEC
34
Crédit Industriel et Commercial
France
– -$11.2M -522,034 Closed
First Trust Advisors
35
First Trust Advisors
Illinois
– -$11.1M -513,928 Closed
Jane Street
36
Jane Street
New York
– -$10.8M -500,561 Closed
GLF
37
Groupe la Francaise
France
– -$10.3M -479,291 Closed
Verition Fund Management
38
Verition Fund Management
Connecticut
– -$9.72M -450,981 Closed
Squarepoint
39
Squarepoint
New York
– -$9.05M -420,072 Closed
Ameriprise
40
Ameriprise
Minnesota
– -$7.58M -351,924 Closed
UBS Group
41
UBS Group
Switzerland
– -$7.43M -344,933 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
42
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$7.27M -337,481 Closed
AIC
43
AWM Investment Company
New York
– -$6.81M -316,189 Closed
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
– -$6.48M -300,677 Closed
HM
45
Harvest Management
New York
– -$6.46M -300,000 Closed
GCIA
46
Gabelli & Co Investment Advisers
New York
– -$6.41M -297,566 Closed
GF
47
Gabelli Funds
New York
– -$6.11M -283,734 Closed
Point72 Asset Management
48
Point72 Asset Management
Connecticut
– -$6.02M -279,525 Closed
Renaissance Technologies
49
Renaissance Technologies
New York
– -$5.9M -273,600 Closed
WC
50
Wexford Capital
Florida
– -$5.88M -272,821 Closed
1
2
3 4 5

AVDL Hedge Fund Activity: Q1 2026 in Review

2 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2026, worth a combined $442 — down 100% from $1.6B a quarter earlier.

Sellers outnumbered buyers: 202 funds closed out of AVDL and 0 opened new positions — a net loss of 202 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $152M sold.

  • 2 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2026, down from 207 in Q4 2025.
  • Funds reported $442 of Avadel Pharmaceuticals stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avadel Pharmaceuticals positions in Q1 2026 and 202 closed out, a net change of -202 holders.
  • The largest Avadel Pharmaceuticals seller in Q1 2026 was BlackRock, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2026.